Zoledronic Acid Market Size, Share & Growth Analysis By Product (Injection, Powder), By End-User (Metastatic Bone Cancers, Systemic Metabolic Bone Diseases), And Regional Forecast, 2022-2028

Report Summary

Zoledronic acid, also known as zoledronate, is a medication used to treat a number of bone diseases. These include osteoporosis, high blood calcium due to cancer, bone breakdown due to cancer, and Paget's disease of bone. It is given by injection into a vein. The global Zoledronic Acid market is valued at xx million US$ in 2020 and will reach xx million US$ by the end of 2027, growing at a CAGR of xx% during 2021-2027. The objectives of this study are to define, segment, and project the size of the Zoledronic Acid market based on company, product type, end user and key regions. This report studies the global market size of Zoledronic Acid in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Zoledronic Acid in these regions. This research report categorizes the global Zoledronic Acid market by top players/brands, region, type and end user. This report also studies the global Zoledronic Acid market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors. The following manufacturers are covered in this report, with sales, revenue, market share for each company:

• Mylan
• Eli Lilly
• Pfizer
• Apotex
• Teva
• Amgen
• Tecoland
• Novartis
• Emcure Pharma
• Taj Pharmaceuticals
• Natco Pharma
• Scinopharm Taiwan
• Lianyungang Runzhong Pharmaceutical
• Hangzhou Longshine Bio-Tech

By Product

• Injection
• Powder

By End-User

• Metastatic Bone Cancers
• Systemic Metabolic Bone Diseases

Market size by Region

• North America
  • United States
  • Canada
  • Mexico
• Asia-Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Singapore
  • Malaysia
  • Philippines
  • Thailand
  • Vietnam
• Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
• Central & South America
  • Brazil
  • Rest of Central & South America
• Middle East & Africa
  • GCC Countries
  • Turkey
  • Egypt
  • South Africa

The study objectives of this report are:

• To study and analyze the global Zoledronic Acid market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
• To understand the structure of Zoledronic Acid market by identifying its various subsegments.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• Focuses on the key global Zoledronic Acid companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
• To project the value and sales volume of Zoledronic Acid submarkets, with respect to key regions.
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Zoledronic Acid are as follows: History Year: 2017-2020 Base Year: 2020 Estimated Year: 2020 Forecast Year 2021 to 2027 This report includes the estimation of market size for value (million US$) and volume (MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Zoledronic Acid market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources. For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table Of Contents

Table of Contents

1 Study Coverage
1.1 Zoledronic Acid Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Zoledronic Acid Market Size Growth Rate by Product
1.4.2 Injection
1.4.3 Powder
1.5 Market by End User
1.5.1 Global Zoledronic Acid Market Size Growth Rate by End User
1.5.2 Metastatic Bone Cancers
1.5.3 Systemic Metabolic Bone Diseases
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Zoledronic Acid Market Size
2.1.1 Global Zoledronic Acid Revenue 2017-2027
2.1.2 Global Zoledronic Acid Sales 2017-2027
2.2 Zoledronic Acid Growth Rate by Regions
2.2.1 Global Zoledronic Acid Sales by Regions
2.2.2 Global Zoledronic Acid Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Zoledronic Acid Sales by Manufacturers
3.1.1 Zoledronic Acid Sales by Manufacturers
3.1.2 Zoledronic Acid Sales Market Share by Manufacturers
3.1.3 Global Zoledronic Acid Market Concentration Ratio (CR5 and HHI)
3.2 Zoledronic Acid Revenue by Manufacturers
3.2.1 Zoledronic Acid Revenue by Manufacturers (2017-2020)
3.2.2 Zoledronic Acid Revenue Share by Manufacturers (2017-2020)
3.3 Zoledronic Acid Price by Manufacturers
3.4 Zoledronic Acid Manufacturing Base Distribution, Product Types
3.4.1 Zoledronic Acid Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Zoledronic Acid Product Type
3.4.3 Date of International Manufacturers Enter into Zoledronic Acid Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Zoledronic Acid Sales by Product
4.2 Global Zoledronic Acid Revenue by Product
4.3 Zoledronic Acid Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Zoledronic Acid Breakdown Data by End User

6 North America
6.1 North America Zoledronic Acid by Countries
6.1.1 North America Zoledronic Acid Sales by Countries
6.1.2 North America Zoledronic Acid Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Zoledronic Acid by Product
6.3 North America Zoledronic Acid by End User

7 Europe
7.1 Europe Zoledronic Acid by Countries
7.1.1 Europe Zoledronic Acid Sales by Countries
7.1.2 Europe Zoledronic Acid Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Zoledronic Acid by Product
7.3 Europe Zoledronic Acid by End User

8 Asia Pacific
8.1 Asia Pacific Zoledronic Acid by Countries
8.1.1 Asia Pacific Zoledronic Acid Sales by Countries
8.1.2 Asia Pacific Zoledronic Acid Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Zoledronic Acid by Product
8.3 Asia Pacific Zoledronic Acid by End User

9 Central & South America
9.1 Central & South America Zoledronic Acid by Countries
9.1.1 Central & South America Zoledronic Acid Sales by Countries
9.1.2 Central & South America Zoledronic Acid Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Zoledronic Acid by Product
9.3 Central & South America Zoledronic Acid by End User

10 Middle East and Africa
10.1 Middle East and Africa Zoledronic Acid by Countries
10.1.1 Middle East and Africa Zoledronic Acid Sales by Countries
10.1.2 Middle East and Africa Zoledronic Acid Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Zoledronic Acid by Product
10.3 Middle East and Africa Zoledronic Acid by End User

11 Company Profiles
11.1 Mylan
11.1.1 Mylan Company Details
11.1.2 Company Business Overview
11.1.3 Mylan Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Mylan Zoledronic Acid Products Offered
11.1.5 Mylan Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Company Business Overview
11.2.3 Eli Lilly Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Eli Lilly Zoledronic Acid Products Offered
11.2.5 Eli Lilly Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Company Business Overview
11.3.3 Pfizer Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Pfizer Zoledronic Acid Products Offered
11.3.5 Pfizer Recent Development
11.4 Apotex
11.4.1 Apotex Company Details
11.4.2 Company Business Overview
11.4.3 Apotex Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Apotex Zoledronic Acid Products Offered
11.4.5 Apotex Recent Development
11.5 Teva
11.5.1 Teva Company Details
11.5.2 Company Business Overview
11.5.3 Teva Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Teva Zoledronic Acid Products Offered
11.5.5 Teva Recent Development
11.6 Amgen
11.6.1 Amgen Company Details
11.6.2 Company Business Overview
11.6.3 Amgen Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Amgen Zoledronic Acid Products Offered
11.6.5 Amgen Recent Development
11.7 Tecoland
11.7.1 Tecoland Company Details
11.7.2 Company Business Overview
11.7.3 Tecoland Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Tecoland Zoledronic Acid Products Offered
11.7.5 Tecoland Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Company Business Overview
11.8.3 Novartis Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Novartis Zoledronic Acid Products Offered
11.8.5 Novartis Recent Development
11.9 Emcure Pharma
11.9.1 Emcure Pharma Company Details
11.9.2 Company Business Overview
11.9.3 Emcure Pharma Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Emcure Pharma Zoledronic Acid Products Offered
11.9.5 Emcure Pharma Recent Development
11.10 Taj Pharmaceuticals
11.10.1 Taj Pharmaceuticals Company Details
11.10.2 Company Business Overview
11.10.3 Taj Pharmaceuticals Zoledronic Acid Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Taj Pharmaceuticals Zoledronic Acid Products Offered
11.10.5 Taj Pharmaceuticals Recent Development
11.11 Natco Pharma
11.12 Scinopharm Taiwan
11.13 Lianyungang Runzhong Pharmaceutical
11.14 Hangzhou Longshine Bio-Tech

12 Future Forecast
12.1 Zoledronic Acid Market Forecast by Regions
12.1.1 Global Zoledronic Acid Sales Forecast by Regions 2021-2027
12.1.2 Global Zoledronic Acid Revenue Forecast by Regions 2021-2027
12.2 Zoledronic Acid Market Forecast by Product
12.2.1 Global Zoledronic Acid Sales Forecast by Product 2021-2027
12.2.2 Global Zoledronic Acid Revenue Forecast by Product 2021-2027
12.3 Zoledronic Acid Market Forecast by End User
12.4 North America Zoledronic Acid Forecast
12.5 Europe Zoledronic Acid Forecast
12.6 Asia Pacific Zoledronic Acid Forecast
12.7 Central & South America Zoledronic Acid Forecast
12.8 Middle East and Africa Zoledronic Acid Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Zoledronic Acid Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer